Peptide Based Gastrointestinal Disorders Therapeutics Market
Peptide Based Gastrointestinal Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022
Analysis of Peptide Based Gastrointestinal Disorders Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT190MR
- 16 Aug 2017
- Healthcare
- 170 Pages
- 140 Tables
- 42 Figures
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By Drug
- 3.1. Teduglutide
- 3.2. Linaclotide
- 4. Global Market Analysis and Forecast By Distribution Channel
- 4.1. Hospital Pharmacies
- 4.2. Retail Pharmacies
- 4.3. Online Pharmacies
- 5. Global Market Analysis and Forecast By Region
- 5.1. North America
- 5.2. Latin America
- 5.3. Europe
- 5.4. Japan
- 5.5. APEJ
- 5.6. MEA
- 6. North America Market Analysis and Forecast, By Country, 2012 to 2022
- 7. Latin America Market Analysis and Forecast, By Country, 2012 to 2022
- 8. Europe Market Analysis and Forecast, By Country, 2012 to 2022
- 9. Japan Market Analysis and Forecast, By Country, 2012 to 2022
- 10. APEJ Market Analysis and Forecast, By Country, 2012 to 2022
- 11. MEA Market Analysis and Forecast, By Country, 2012 to 2022
- 12. Global Market Competition Landscape and Company Profile
- 12.1. Shire plc
- 12.2. Ironwood Pharmaceuticals, Inc
- 12.3. Astellas Pharma Inc
- 12.4. Allergan plc
- 12.5. Accredo Health Group, Inc
- 13. Research Methodology
- 14. Secondary and Primary Sources
- 15. Assumptions and Acronyms
- 16. Disclaimer
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2012 to 2016
TABLE 02: Global Market Value (US$ Mn), 2017 to 2022
TABLE 3 :Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2022
TABLE 04: Global Teduglutide Segment Value (US$ Mn), By Region 2012 to 2016
TABLE 05: Global Teduglutide Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 06: Global Teduglutide Segment Market Share, By Region 2012 to 2016
TABLE 07: Global Teduglutide Segment Market Share, By Region 2017 to 2022
TABLE 08: Global Teduglutide Segment Y-o-Y, By Region 2015 to 2022
TABLE 09: Global Linaclotide Segment Value (US$ Mn), By Region 2012 to 2016
TABLE 10: Global Linaclotide Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 11: Global Linaclotide Segment Market Share, By Region 2012 to 2016
TABLE 12: Global Linaclotide Segment Market Share, By Region 2017 to 2022
TABLE 13: Global Linaclotide Segment Y-o-Y, By Region 2015 to 2022
TABLE 14: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016
TABLE 15: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 16: Global Hospital Pharmacies Segment Market Share, By Region 2012 to 2016
TABLE 17: Global Hospital Pharmacies Segment Market Share, By Region 2017 to 2022
TABLE 18: Global Hospital Pharmacies Segment Y-o-Y, By Region 2015 to 2022
TABLE 19: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016
TABLE 20: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 21: Global Retail Pharmacies Segment Market Share, By Region 2012 to 2016
TABLE 22: Global Retail Pharmacies Segment Market Share, By Region 2017 to 2022
TABLE 23: Global Retail Pharmacies Segment Y-o-Y, By Region 2015 to 2022
TABLE 24: Global Online Pharmacies Segment Value (US$ Mn), By Region 2012 to 2016
TABLE 25: Global Online Pharmacies Segment Value (US$ Mn), By Region 2017 to 2022
TABLE 26: Global Online Pharmacies Segment Market Share, By Region 2012 to 2016
TABLE 27: Global Online Pharmacies Segment Market Share, By Region 2017 to 2022
TABLE 28: Global Online Pharmacies Segment Y-o-Y, By Region 2015 to 2022
TABLE 29: North America Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 30: North America Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 31: North America Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 32: North America Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 33: Latin America Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 34: Latin America Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 35: Latin America Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 36: Latin America Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 37: Europe Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 38: Europe Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 39: Europe Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 40: Europe Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 41: Japan Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 42: Japan Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 43: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 44: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 45: APEJ Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 46: APEJ Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 47: APEJ Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 48: APEJ Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 49: MEA Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 50: MEA Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 51: MEA Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 52: MEA Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 53: US Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 54: US Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 55: US Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 56: US Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 57: Canada Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 58: Canada Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 59: Canada Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 60: Canada Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 61: Brazil Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 62: Brazil Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 63: Brazil Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 64: Brazil Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 65: Mexico Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 66: Mexico Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 67: Mexico Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 68: Mexico Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 69: Argentina Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 70: Argentina Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 71: Argentina Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 72: Argentina Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 73: Germany Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 74: Germany Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 75: Germany Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 76: Germany Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 77: UK Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 78: UK Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 79: UK Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 80: UK Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 81: France Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 82: France Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 83: France Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 84: France Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 85: Spain Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 86: Spain Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 87: Spain Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 88: Spain Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 89: Italy Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 90: Italy Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 91: Italy Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 92: Italy Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 93: Nordic Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 94: Nordic Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 95: Nordic Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 96: Nordic Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 97: Japan Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 98: Japan Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 99: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 100: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 101: China Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 102: China Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 103: China Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 104: China Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 105: India Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 106: India Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 107: India Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 108: India Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 109: Malaysia Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 110: Malaysia Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 111: Malaysia Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 112: Malaysia Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 113: Thailand Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 114: Thailand Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 115: Thailand Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 116: Thailand Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 117: Singapore Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 118: Singapore Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 119: Singapore Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 120: Singapore Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 121: Australia Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 122: Australia Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 123: Australia Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 124: Australia Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 125: GCC Countries Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 126: GCC Countries Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 127: GCC Countries Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 128: GCC Countries Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 129: South Africa Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 130: South Africa Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 131: South Africa Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 132: South Africa Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 133: Nigeria Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 134: Nigeria Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 135: Nigeria Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 136: Nigeria Market Value (US$ Mn), By Distribution Channel 2017 to 2022
TABLE 137: Israel Market Value (US$ Mn), By Drug 2012 to 2016
TABLE 138: Israel Market Value (US$ Mn), By Drug 2017 to 2022
TABLE 139: Israel Market Value (US$ Mn), By Distribution Channel 2012 to 2016
TABLE 140: Israel Market Value (US$ Mn), By Distribution Channel 2017 to 2022
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2012 to 2016
FIG. 02: Global Market Value (US$ Mn) Forecast, 2017 to 2022
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2022
FIG. 04: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2012 to 2016
FIG. 05: Global Teduglutide Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 06: Global Teduglutide Segment Y-o-Y Growth Rate, By Region, 2015 to 2022
FIG. 07: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2012 to 2016
FIG. 08: Global Linaclotide Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 09: Global Linaclotide Segment Y-o-Y Growth Rate, By Region, 2015 to 2022
FIG. 10: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016
FIG. 11: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 12: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022
FIG. 13: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016
FIG. 14: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 15: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022
FIG. 16: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2016
FIG. 17: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017 to 2022
FIG. 18: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015 to 2022
FIG. 19: North America Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 20: North America Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 21: North America Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 22: North America Market Value (US$ Mn), By Distribution Channel 2017 to 2022
FIG. 23: Latin America Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 24: Latin America Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 25: Latin America Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 26: Latin America Market Value (US$ Mn), By Distribution Channel 2017 to 2022
FIG. 27: Europe Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 28: Europe Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 29: Europe Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 30: Europe Market Value (US$ Mn), By Distribution Channel 2017 to 2022
FIG. 31: Japan Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 32: Japan Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 33: Japan Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 34: Japan Market Value (US$ Mn), By Distribution Channel 2017 to 2022
FIG. 35: APEJ Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 36: APEJ Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 37: APEJ Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 38: APEJ Market Value (US$ Mn), By Distribution Channel 2017 to 2022
FIG. 39: MEA Market Value (US$ Mn), By Drug 2012 to 2016
FIG. 40: MEA Market Value (US$ Mn), By Drug 2017 to 2022
FIG. 41: MEA Market Value (US$ Mn), By Distribution Channel 2012 to 2016
FIG. 42: MEA Market Value (US$ Mn), By Distribution Channel 2017 to 2022
Peptide Based Gastrointestinal Disorders Therapeutics Market